US FDA asks for 19% increase in FY 2010 budget, proposes new user fees programmes
This article was originally published in RAJ Devices
The Food and Drug Administration, in its budget request for fiscal year 2010, has asked Congress for funds totalling $3.2 billion1-3. The amount is $511 million more than the FY 2009 budget and would represent a 19% increase – the largest ever in the agency’s history.
You may also be interested in...
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.